186 related articles for article (PubMed ID: 21720503)
1. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.
Xu N; Gu J; Zhu Y; Wen H; Ren Q; Chen J
Int J Nanomedicine; 2011; 6():905-13. PubMed ID: 21720503
[TBL] [Abstract][Full Text] [Related]
2. A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection.
Shao K; Wu J; Chen Z; Huang S; Li J; Ye L; Lou J; Zhu L; Jiang C
Biomaterials; 2012 Oct; 33(28):6898-907. PubMed ID: 22789719
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of amphotericin B in the cerebrospinal fluid during continuous intrathecal administration for treatment of cryptococcal neoformans meningitis].
Fang M; Lv TM; Yan Y; Liu ST; Gao WH; Liu XJ; Yin J; Wang L; Wang YY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1929-31. PubMed ID: 22126783
[TBL] [Abstract][Full Text] [Related]
4. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
[TBL] [Abstract][Full Text] [Related]
5. Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity.
Tang X; Liang Y; Zhu Y; Xie C; Yao A; Chen L; Jiang Q; Liu T; Wang X; Qian Y; Wei J; Ni W; Dai J; Jiang Z; Hou W
Int J Nanomedicine; 2015; 10():6227-41. PubMed ID: 26491294
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Gazzoni AF; Capilla J; Mayayo E; Guarro J
Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
[TBL] [Abstract][Full Text] [Related]
7. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B.
Pedroso LS; Khalil NM; Mainardes RM
Curr Drug Deliv; 2018; 15(7):1055-1063. PubMed ID: 29629661
[TBL] [Abstract][Full Text] [Related]
8. Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans.
Chintalacharuvu KR; Matolek ZA; Pacheco B; Carriera EM; Beenhouwer DO
Med Mycol; 2021 Nov; 59(11):1085-1091. PubMed ID: 34332505
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficiency of amphotericin B liposome modified by RMP-7 to transport drug across blood brain barrier].
Zhang XB; Yuan S; Lei PC; Hou XP
Yao Xue Xue Bao; 2004 Apr; 39(4):292-5. PubMed ID: 15303662
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients.
Joly V; Geoffray C; Reynes J; Goujard C; Méchali D; Maslo C; Raffi F; Yeni P
J Antimicrob Chemother; 1996 Jul; 38(1):117-26. PubMed ID: 8858463
[TBL] [Abstract][Full Text] [Related]
11. Influence of the progression of cryptococcal meningitis on brain penetration and efficacy of AmBisome in a murine model.
Takemoto K; Yamamoto Y; Ueda Y
Chemotherapy; 2006; 52(6):271-8. PubMed ID: 16988503
[TBL] [Abstract][Full Text] [Related]
12. Clinical study on liposomal amphotericin B (Ambisome) in deep fungal infections in China.
Wei H; Hai W; Wanqing L
Mycoses; 2003 Feb; 46(1-2):24-8. PubMed ID: 12588479
[TBL] [Abstract][Full Text] [Related]
13. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
[TBL] [Abstract][Full Text] [Related]
14. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
16. Brain glucose induces tolerance of Cryptococcus neoformans to amphotericin B during meningitis.
Chen L; Tian X; Zhang L; Wang W; Hu P; Ma Z; Li Y; Li S; Shen Z; Fan X; Ye L; Ke W; Wu Y; Shui G; Xiao M; He GJ; Yang Y; Fang W; Bai F; Liao G; Chen M; Lin X; Li C; Wang L
Nat Microbiol; 2024 Feb; 9(2):346-358. PubMed ID: 38225460
[TBL] [Abstract][Full Text] [Related]
17. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
Lestner J; McEntee L; Johnson A; Livermore J; Whalley S; Schwartz J; Perfect JR; Harrison T; Hope W
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320715
[TBL] [Abstract][Full Text] [Related]
18. [A case of cryptococcal meningitis successfully treated with placing Ommaya reservoir into ventricle].
Jiang PF; Zhu T
Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):470-1. PubMed ID: 16053741
[No Abstract] [Full Text] [Related]
19. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
20. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
